SARS-Cov-2 Family: Characteristics and Clinical Manifestation and Presentation of Covid – 19: Descriptive Minireview
Main Article Content
Abstract
Corona virus is not a single virus, but rather a large family of coronaviruses that cause disease in humans and animals. The severity of symptoms of infection with one of the types of coronavirus in humans ranges from the common cold to severe acute respiratory infection (SARS). The Middle East Respiratory Syndrome Corona virus (MERS-CoV) was first discovered in April 2012, when it was not known to humans, and it was causing severe illness in people with it and the death of half of the cases of infection. With the emerging corona virus (19-COVID), which has led to the death of a large number of people and confused life in all countries of the world nearly 6 million people have died all over the world. The aim of this descriptive minireview, generally, is to shed light on the SARS-CoV-2 family : Characteristics and Clinical manifestation and presentation of Covid – 19
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Wu YC, Chen CS, Chan YJ. The outbreak of COVID-19: An overview. J Chin Med Assoc. 2020;83(3):217-220. doi:10.1097/JCMA.0000000000000270
II. World Health Organization. Novel Coronavirus (2019-nCoV) Available at https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed February 7, 2020.
III. Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, et al. ; HKU/UCH SARS Study Group Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 20033611767–72
IV. H.A. Rothan, S.N. Byrareddy .The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimm (2020), 10.1016/j.jaut.2020.102433
V. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020
DOI: 10.1016/S0140-6736(20)30251.
VI. Wang W, Tang J, Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J Med Virol. 2020
DOI: 10.1002/jmv.25689.
VII. Xu, B., Gutierrez, B., Mekaru, S. et al. Epidemiological data from the COVID-19 outbreak, real-time case information. Sci Data 7, 106 (2020).
https://doi.org/10.1038/s41597-020-0448-0
VIII. Li, Q. et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia. N. Engl. J. Med. (2020).
NEJMoa2001316, https://doi.org/10.1056/NEJMoa2001316
IX. Zhao, S. et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak. Int. J. Infect. Dis. (2020).
https://doi.org/10.1016/j.ijid.2020.01.050
X. Xu, B. & Kraemer, M. U. G. Open access epidemiological data from the COVID-19. Lancet Infect. Dis. (2020). 3099, 30119